Related Experiment Video
Updated: Oct 21, 2025

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
Published on: August 15, 2020
Neuroprotective Effects of Neuropeptide Y against Neurodegenerative Disease
Stéphanie Pain1,2, Sébastien Brot1, Afsaneh Gaillard1
1Laboratoire de Neurosciences Expérimentales et Cliniques-LNEC INSERM U-1084, Université de Poitiers, LNEC, F-86000 Poitiers, France.
Abstract:
Neuropeptide Y (NPY), a 36 amino acid peptide, is widely expressed in the mammalian brain. Changes in NPY levels in different brain regions and plasma have been described in several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis, and Machado-Joseph disease. The changes in NPY levels may reflect the attempt to set up an endogenous neuroprotective mechanism to counteract the degenerative process. Accumulating evidence indicates that NPY can function as an anti-apoptotic, anti-inflammatory, and pro-phagocytic agent, which may be used effectively to halt or to slow down the progression of the disease. In this review, we will focus on the neuroprotective roles of NPY in several neuropathological conditions, with a particular focus on the anti-inflammatory properties of NPY.
More Related Videos
09:50Experimental Methods for Testing the Effects of Neurotrophic Peptide, ADNF-9, Against Alcohol-induced Apoptosis during Pregnancy in C57BL/6 Mice
Published on: April 24, 2013
06:23Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Neural Regulation
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists